News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GOLDFISCHER CARL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Galecto, Inc.|
Txns:
| Granted 36,000 options to buy
@ $1.98, valued at
$71.3k
|
|
| 06/03/2022 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Granted 8,500 options to buy
@ $1.07, valued at
$9.1k
|
|
| 05/19/2022 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,994 shares
@ $0
Granted 41,006 options to buy
@ $0.56, valued at
$23k
|
|
| 11/19/2021 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Galecto, Inc.|
Txns:
| Granted 18,000 options to buy
@ $3.23, valued at
$58.1k
|
|
| 06/30/2021 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Granted 7,728 options to buy
@ $8.12, valued at
$62.8k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Galecto, Inc.|
Txns:
| Granted 18,000 options to buy
@ $4.93, valued at
$88.7k
|
|
| 11/13/2020 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Bought 5,000 shares
@ $12.07, valued at
$60.4k
|
|
| 11/04/2020 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Galecto, Inc.|
Txns:
| Converted 9,587 shares
@ $0
Converted 1,020,036 shares
@ $0
Converted 19,432 shares
@ $0
Granted 3,688 preferred shares
@ $27.11, valued at
$100k
Converted 392,367 options to buy
@ $0
Converted 7,475 options to buy
@ $0
Converted 3,688 preferred shares
@ $0 |
|
| 10/28/2020 |
3
| GOLDFISCHER CARL (Director) has filed a Form 3 on Galecto Inc. |
| 06/02/2020 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 14,013 options to buy
@ $17.55, valued at
$245.9k
|
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/07/2019 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 17,633 options to buy
@ $13.74, valued at
$242.3k
|
|
| 02/08/2019 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 11,675 shares
@ $9.0217, valued at
$105.3k
Exercised 2,335 options to buy
@ $5, valued at
$11.7k
Exercised 9,340 options to buy
@ $5.5, valued at
$51.4k
|
|
| 01/31/2019 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 27,705 options to buy
@ $8.43, valued at
$233.6k
|
|
| 05/31/2018 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $17, valued at
$212.5k
|
|
| 03/23/2018 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $13.025, valued at
$195.4k
Exercised 6,470 options to buy
@ $5, valued at
$32.4k
Exercised 2,870 options to buy
@ $5, valued at
$14.4k
Exercised 5,660 options to buy
@ $5.5, valued at
$31.1k
|
|
| 01/26/2018 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $11.69, valued at
$187k
|
|
| 11/06/2017 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 18,000 shares
@ $8.66, valued at
$155.9k
Exercised 9,000 options to buy
@ $1.72, valued at
$15.5k
Exercised 9,000 options to buy
@ $2.97, valued at
$26.7k
|
|
| 09/26/2017 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $7.47, valued at
$56k
|
|
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2017 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.65, valued at
$170.6k
|
|
| 05/31/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2016 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc. |
| 05/23/2016 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 12,500 options to buy
@ $9.33, valued at
$116.6k
|
|
| 05/17/2016 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on EnteroMedics Inc|
Txns:
| Granted 3,000 options to buy
@ $0.75, valued at
$2.3k
|
|
| 01/12/2016 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Bought 545,166 shares
@ $9, valued at
$4.9M
Bought 10,389 shares
@ $9, valued at
$93.5k
|
|
| 09/11/2015 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 13 shares
@ $2.76, valued at
$35.9
Sold 13,844 shares
@ $2.76, valued at
$38.2k
Sold 905 shares
@ $2.76, valued at
$2.5k
Sold 15 shares
@ $2.71, valued at
$40.7
Sold 15,474 shares
@ $2.71, valued at
$41.9k
Sold 1,011 shares
@ $2.71, valued at
$2.7k
Sold 13 shares
@ $2.77, valued at
$36
Sold 14,506 shares
@ $2.76, valued at
$40k
Sold 948 shares
@ $2.76, valued at
$2.6k
|
|
| 07/10/2015 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 7,333 options to buy
@ $22.78, valued at
$167k
|
|
| 06/30/2015 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $2.97, valued at
$26.7k
|
|
|
|
|